Document is current
Any future updates will be listed below
-
Authors
Johnson, Amanda M. https://orcid.org/0000-0003-2838-0538
Storm, Andrew C.
Mahmoud, Tala
Ghazi, Rabih
Rapaka, Babusai
Abboud, Donna M.
Loftus, Edward V. Jr.
Dayyeh, Barham K. Abu
- License Information
-
More Information
Article History
Received: 18 July 2022
Revised: 21 November 2022
Accepted: 27 November 2022
First Online: 7 December 2022
Declarations
:
: Given the nature of this study, formal consent is not required.
: AMJ, TM, RG, BR, DMA: No relevant conflicts of interest to disclose.ACS: Consulting for Apollo Endosurgery, GI Dynamics, Olympus, ERBE, and Intuitive and the recipient of research support from Apollo Endosurgery, Endo-TAGSS, Enterasense, Endogenex, and Boston Scientific.EVL: Consulting for AbbVie, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Calibr, Celgene, Eli Lilly, Genentech, Gilead, Gossamer Bio, Iterative Scopes, Janssen, Morphic, Ono Pharma, Pfizer, Protagonist, Scipher Medicine, Sun Pharma, Surrozen, Takeda, and UCB and research support from AbbVie, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Gossamer Bio, Janssen, Pfizer, Receptos, Theravance, Takeda, and UCB.BKA: Consulting for Endogenex, Endo-TAGSS, Metamodix, and BFKW; consultant and grant/research support from USGI, Cairn Diagnostics, Aspire Bariatrics, and Boston Scientific; speaker roles with Olympus and Johnson and Johnson; speaker and grant/research support from Medtronic, and Endogastric solutions; and research support from Apollo Endosurgery and Spatz Medical.
